
Semaglutide is a synthetic peptide analog of the incretin hormone glucagon-like peptide-1 (GLP-1) investigated in experimental and clinical research as a regulator of metabolic signaling and endocrine pathways associated with glucose homeostasis and energy balance. Structural modifications incorporated into the peptide enhance enzymatic stability and extend circulating half-life, allowing researchers to study prolonged GLP-1 receptor activation under controlled experimental conditions.


Videos de creadores independientes en YouTube. BioVantix no los produce ni los respalda, y no son instrucciones de uso. Se cargan desde YouTube solo al reproducirlos.